{"id":"https://openalex.org/W3213664447","doi":"https://doi.org/10.1182/blood-2021-148064","title":"Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias","display_name":"Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3213664447","doi":"https://doi.org/10.1182/blood-2021-148064","mag":"3213664447"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-148064","doi":"https://doi.org/10.1182/blood-2021-148064","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148064","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025662872","display_name":"Mona Mohamed Hamdy","orcid":"https://orcid.org/0000-0002-1783-6133","observed_orcids":["https://orcid.org/0000-0002-1783-6133"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mona Hamdy","raw_affiliation_strings":["Department of Pediatrics, School of Medicine, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, School of Medicine, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069567664","display_name":"Amal M. El-Beshlawy","orcid":"https://orcid.org/0000-0003-3293-1806","observed_orcids":["https://orcid.org/0000-0003-3293-1806"]},"institutions":[{"id":"https://openalex.org/I4210164576","display_name":"Cairo University hospitals","ror":"https://ror.org/058djb788","country_code":"EG","type":"healthcare","lineage":["https://openalex.org/I4210164576"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Amal El-Beshlawy","raw_affiliation_strings":["Department of Pediatric Hematology, Pediatric Hospital of Cairo University, Sayeda Zeneb,Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology, Pediatric Hospital of Cairo University, Sayeda Zeneb,Cairo, Egypt","institution_ids":["https://openalex.org/I4210164576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001077296","display_name":"Fatma Soliman Elsayed Ebeid","orcid":"https://orcid.org/0000-0002-3761-6373","observed_orcids":["https://orcid.org/0000-0002-3761-6373"]},"institutions":[{"id":"https://openalex.org/I107720978","display_name":"Ain Shams University","ror":"https://ror.org/00cb9w016","country_code":"EG","type":"education","lineage":["https://openalex.org/I107720978"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Fatma Soliman Elsayed Ebeid","raw_affiliation_strings":["Pediatric Hematology/Oncology and BMT, Faculty of Medicine, Ain Shams University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Hematology/Oncology and BMT, Faculty of Medicine, Ain Shams University, Cairo, Egypt","institution_ids":["https://openalex.org/I107720978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079102665","display_name":"Janet L. Kwiatkowski","orcid":"https://orcid.org/0000-0001-7103-3406","observed_orcids":["https://orcid.org/0000-0001-7103-3406"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet L. Kwiatkowski","raw_affiliation_strings":["Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA","Division of Hematology, Children's Hospital of Philadephia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Division of Hematology, Children's Hospital of Philadephia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064328568","display_name":"Julie Kanter","orcid":"https://orcid.org/0000-0001-7002-8891","observed_orcids":["https://orcid.org/0000-0001-7002-8891"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Kanter","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine, University of Alabama-Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, University of Alabama-Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009513049","display_name":"Baba P. D. Inusa","orcid":"https://orcid.org/0000-0003-2643-765X","observed_orcids":["https://orcid.org/0000-0003-2643-765X"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I1324925910","display_name":"St Thomas' Hospital","ror":"https://ror.org/054gk2851","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324925910","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210144851","display_name":"Evelina London Children's Healthcare","ror":"https://ror.org/058pgtg13","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805","https://openalex.org/I4210144851"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Baba PD Inusa","raw_affiliation_strings":["Paediatric Haematology, Evelina Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paediatric Haematology, Evelina Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I1324925910","https://openalex.org/I200166805","https://openalex.org/I4210144851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029639633","display_name":"Suzan A. Williams","orcid":"https://orcid.org/0000-0002-9321-4301","observed_orcids":["https://orcid.org/0000-0002-9321-4301"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Suzan Williams","raw_affiliation_strings":["Department of Haematology and Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology and Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100423785","display_name":"David J. Lee","orcid":"https://orcid.org/0000-0002-7536-9692","observed_orcids":["https://orcid.org/0000-0002-7536-9692","https://orcid.org/0000-0001-6691-2764","https://orcid.org/0009-0006-5423-4525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Lee","raw_affiliation_strings":["Chiesi Canada Corporation, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Canada Corporation, Toronto, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049912487","display_name":"Noemi Toiber Temin","orcid":"https://orcid.org/0009-0000-4347-9988","observed_orcids":["https://orcid.org/0009-0000-4347-9988"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noemi T Temin","raw_affiliation_strings":["Hematology/Immunology Program, Chiesi Rare Disease, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Immunology Program, Chiesi Rare Disease, Toronto, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090965296","display_name":"Caroline Fradette","orcid":"https://orcid.org/0009-0009-8004-0304","observed_orcids":["https://orcid.org/0009-0009-8004-0304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Fradette","raw_affiliation_strings":["Chiesi Canada Corporation, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Canada Corporation, Toronto, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030306815","display_name":"Fernando Tricta","orcid":"https://orcid.org/0000-0003-2105-5281","observed_orcids":["https://orcid.org/0000-0003-2105-5281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernando Tricta","raw_affiliation_strings":["Chiesi Canada Corporation, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Canada Corporation, Toronto, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030910487","display_name":"Mohsen Saleh Elalfy","orcid":"https://orcid.org/0000-0002-2809-1552","observed_orcids":["https://orcid.org/0000-0002-2809-1552"]},"institutions":[{"id":"https://openalex.org/I107720978","display_name":"Ain Shams University","ror":"https://ror.org/00cb9w016","country_code":"EG","type":"education","lineage":["https://openalex.org/I107720978"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohsen Saleh Elalfy","raw_affiliation_strings":["Pediatric Hematology/Oncology and BMT, Ain Shams University, Faculty of Medicine, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Hematology/Oncology and BMT, Ain Shams University, Faculty of Medicine, Cairo, Egypt","institution_ids":["https://openalex.org/I107720978"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"762","last_page":"762"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deferiprone","display_name":"deferiprone","score":0.9860000014305115},{"id":"https://openalex.org/keywords/deferoxamine","display_name":"deferoxamine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.8700000047683716},{"id":"https://openalex.org/keywords/transfusional-iron-overload","display_name":"transfusional iron overload","score":0.984000027179718},{"id":"https://openalex.org/keywords/iron-chelation-therapy","display_name":"iron chelation therapy","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.8949999809265137},{"id":"https://openalex.org/keywords/liver-iron-concentration","display_name":"liver iron concentration","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oral-iron-chelators","display_name":"oral iron chelators","score":0.6449999809265137},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5929999947547913},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7139999866485596},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6980000138282776},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.6970000267028809},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.6990000009536743},{"id":"https://openalex.org/keywords/drug-safety-and-efficacy-comparison","display_name":"drug safety and efficacy comparison","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C2776517179","wikidata":"https://www.wikidata.org/wiki/Q749664","display_name":"Deferiprone","level":3,"score":0.897692859172821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8761348724365234},{"id":"https://openalex.org/C2776672577","wikidata":"https://www.wikidata.org/wiki/Q419618","display_name":"Deferoxamine","level":2,"score":0.7794595956802368},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6146239638328552},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5760990381240845},{"id":"https://openalex.org/C2781053155","wikidata":"https://www.wikidata.org/wiki/Q5251502","display_name":"Deferasirox","level":3,"score":0.5425620079040527},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.5286536812782288},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5160943865776062},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47284629940986633},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.4707152247428894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4704626500606537},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.4690834581851959},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46321043372154236},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4288315176963806},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30302396416664124},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14866012334823608}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-148064","doi":"https://doi.org/10.1182/blood-2021-148064","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-148064","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4210650909","https://openalex.org/W2992122126","https://openalex.org/W4387439706","https://openalex.org/W3205153815","https://openalex.org/W3215063928","https://openalex.org/W2338844233","https://openalex.org/W2567717486","https://openalex.org/W2038356980","https://openalex.org/W4210482633","https://openalex.org/W190357846"],"abstract_inverted_index":{"Abstract":[0],"Children":[1,202,439],"with":[2,12,93,109,153,189,291,441,541,574,591,618,655],"sickle":[3],"cell":[4],"disease":[5,10],"(SCD)":[6],"who":[7,195,252,296],"have":[8,673],"their":[9,689],"managed":[11],"frequent":[13],"blood":[14],"transfusions":[15],"often":[16,37],"require":[17],"iron":[18,23,29,74,86,112,118,200,695],"chelation":[19,696],"therapy":[20,644,697],"to":[21,47,62,105,138,149,172,242,353,467,486,536,581,622,659],"prevent":[22],"overload.":[24,201],"Deferoxamine":[25],"(DFO)":[26],"is":[27,36,52,103,657],"an":[28,72,123,468,768,781,793,805,817],"chelator":[30],"approved":[31,79],"for":[32,84,177,198,249,269,319,326,360,512,645],"pediatric":[33,50,89],"use":[34],"that":[35,45,101,388,538,553,582,653,672,698],"administered":[38],"via":[39,317],"infusion;":[40],"however,":[41],"postmarketing":[42],"research":[43],"revealed":[44],"adherence":[46],"treatment":[48,83,367,488,506,654],"in":[49,88,107,151,168,238,333,339,342,365,401,427,449,474,503,519,559,607,615,661,670,678],"populations":[51],"a":[53,81,130,169,215,254,257,375,472,532,577],"key":[54],"challenge":[55],"experienced":[56],"by":[57,116,210,505],"patients":[58,92,108,165,251,295,332],"and":[59,90,95,111,121,143,224,245,256,274,312,322,357,404,411,424,567,688],"caregivers":[60],"due":[61,352,466],"the":[63,67,134,141,222,236,270,280,283,303,330,334,350,381,393,402,422,475,498,514,520,524,594,608,682],"burdensome":[64],"nature":[65],"of":[66,133,145,187,282,302,378,386,395,452,478,571,583,588,600,639,771,784,796,808,820],"administration":[68],"route.":[69],"Deferiprone":[70],"(DFP),":[71],"oral":[73],"chelator,":[75],"has":[76,122],"recently":[77],"been":[78,556,675],"as":[80],"first-line":[82],"transfusional":[85,199],"overload":[87,113],"adult":[91],"SCD":[94,110,190,379,646],"other":[96,361,560,648,679],"anemias.":[97],"We":[98],"previously":[99,557,676],"reported":[100,558],"DFP":[102,146,174,205,442,487,521,537,543,575,619,656],"noninferior":[104],"DFO":[106,150,176,209,444,525,623,660],"(as":[114],"assessed":[115,267],"liver":[117,529],"concentration":[119],"[LIC])":[120],"acceptable":[124],"safety":[125,144,286,335,579,666],"profile.":[126],"Here,":[127],"we":[128],"report":[129],"subgroup":[131,181,637],"analysis":[132,182,292,638],"FIRST":[135],"(NCT02041299)":[136],"study":[137,304,351],"assess":[139],"whether":[140],"efficacy":[142,233,595],"are":[147],"comparable":[148,578,658],"children":[152,184,347,364,504,568,585,616,640,671,687],"SCD.":[154],"In":[155,545,593],"this":[156],"phase":[157],"4,":[158],"multicenter,":[159],"2-arm,":[160],"randomized,":[161],"open-label":[162],"study,":[163],"eligible":[164],"were":[166,196,227,247,266,288,344,407,417,549,668],"randomized":[167],"2:1":[170],"ratio":[171],"receive":[173],"or":[175,191,208,436,443,464,647,773,786,798,810,822],"12":[178,598],"months.":[179],"The":[180,231,508],"included":[183],"(2-16":[185],"years":[186,410,570,587],"age)":[188,589],"another":[192,384],"rare":[193],"anemia":[194,387],"treated":[197,440,573,590,617],"received":[203,297],"either":[204],"orally":[206],"tid":[207],"subcutaneous":[211],"infusion":[212],"5-7":[213],"days":[214],"week.":[216],"Iron":[217],"load":[218],"was":[219,235,315,493,516,527,603],"monitored":[220],"during":[221],"trial":[223],"dosage":[225],"adjustments":[226],"allowed":[228],"when":[229,692],"necessary.":[230],"primary":[232,376],"endpoint":[234],"change":[237,612],"LIC":[239,259,611],"from":[240,349,613],"baseline":[241,255,614],"month":[243],"12,":[244],"data":[246],"analyzed":[248],"all":[250,294],"had":[253,374,383,554],"follow-up":[258],"assessment":[260],"(efficacy":[261],"population).":[262,307],"Absolute":[263],"neutrophil":[264],"counts":[265],"weekly":[268],"first":[271,396],"6":[272],"months,":[273],"then":[275],"every":[276],"2":[277],"weeks":[278],"until":[279],"end":[281],"study.":[284],"Additional":[285],"assessments":[287],"done":[289],"monthly":[290],"including":[293],"at":[298,482],"least":[299,483],"1":[300,496,563,705],"dose":[301],"drug":[305],"(safety":[306],"Statistical":[308],"significance":[309],"between":[310,421],"DFP-":[311,403,423],"DFO-treated":[313,405],"groups":[314,406,426],"calculated":[316],"t-test":[318],"continuous":[320],"variables":[321],"Fisher's":[323],"exact":[324],"test":[325],"discrete":[327],"variables.":[328],"Of":[329],"228":[331],"population,":[336,596],"128":[337],"(n=86":[338],"DFP;":[340],"n=42":[341],"DFO)":[343],"children.":[345],"Five":[346],"withdrew":[348,359],"adverse":[354],"events":[355],"(AEs)":[356],"19":[358],"reasons.":[362],"Most":[363],"each":[366],"group":[368,522,526],"(DFP,":[369],"75.6":[370],"%;":[371],"DFO,":[372],"80.9%)":[373],"diagnosis":[377],"(HbS);":[380],"remainder":[382],"form":[385],"required":[389],"chronic":[390,642],"transfusions.":[391],"At":[392],"time":[394],"exposure,":[397],"mean":[398,609],"ages":[399],"(SD)":[400,610],"9.9":[408],"(3.7)":[409],"10.9":[412],"(3.0)":[413],"(P=0.09),":[414],"respectively.":[415],"There":[416],"no":[418,446,550,604],"significant":[419,447,605],"differences":[420,448],"DFO-treatment":[425],"sex":[428],"(males":[429],"59.3%":[430],"vs":[431,490,523,629],"57.1%;":[432],"P=0.85),":[433],"ethnicity":[434],"(P=0.68),":[435],"race":[437],"(P=0.34).":[438],"showed":[445],"overall":[450,476],"incidence":[451,477],"AEs":[453,459,462,480,502,551],"(P=0.77)":[454],"(including":[455],"neutropenias":[456],"(P=0.30)),":[457],"severe":[458],"(P=0.10),":[460],"serious":[461],"(P=0.16),":[463],"withdrawals":[465],"AE":[469,511],"(P=0.17).":[470],"However,":[471],"difference":[473,606],"nonserious":[479],"considered":[481],"possibly":[484],"related":[485],"(59.3%":[489],"33.3%;":[491],"P=0.01)":[492],"found.":[494],"Table":[495],"shows":[497],"most":[499],"common":[500],"(\u22655%)":[501],"group.":[507],"only":[509],"individual":[510],"which":[513],"rate":[515],"significantly":[517],"higher":[518],"elevated":[528],"enzymes":[530],"(P=0.03),":[531],"known":[533],"transient":[534],"reaction":[535],"typically":[539],"resolves":[540],"continued":[542],"therapy.":[544],"DFP-treated":[546],"children,":[547],"there":[548,602],"observed":[552,669],"not":[555,674],"patient":[561],"populations;":[562],"child":[564],"developed":[565],"agranulocytosis;":[566],"<6":[569],"age":[572],"demonstrated":[576],"profile":[580],"older":[584],"(6-16":[586],"DFP.":[592],"after":[597],"months":[599],"treatment,":[601],"(n=78)":[620],"compared":[621],"(n=40)":[624],"(-3.39":[625],"\u00b1":[626,631],"4.24":[627],"mg/g":[628],"-2.99":[630],"3.16":[632],"mg/g,":[633],"respectively;":[634],"P=0.57).":[635],"This":[636],"receiving":[641],"transfusion":[643],"anemias":[649],"corroborates":[650],"previous":[651],"findings":[652,684],"reducing":[662],"LIC.":[663],"No":[664],"new":[665],"concerns":[667],"noted":[677],"populations.":[680],"Thus,":[681],"present":[683],"may":[685,699],"benefit":[686],"healthcare":[690],"providers":[691],"considering":[693],"effective":[694],"also":[700],"address":[701],"treatment-adherence":[702],"concerns.":[703],"Figure":[704,706],"1.":[707],"Disclosures":[708],"Hamdy:":[709],"Amgen:":[710],"Honoraria;":[711,713,715,717,719,721,743,746,748,830],"Bayer:":[712],"Novartis:":[714,736,763],"ApoPharma:":[716,739],"NovoNordisk:":[718],"Roche:":[720],"Takeda:":[722],"Honoraria.":[723],"Kwiatkowski:":[724],"Terumo":[725],"BCT:":[726],"Research":[727,730,734,737,740],"Funding;":[728,731,735,738,741],"Sangamo:":[729],"Bluebird":[732,753],"Bio:":[733,754,826],"Agios:":[742,789],"Silence":[744],"Therapeutics:":[745],"Celgene:":[747],"Imara:":[749],"Other:":[750,755],"Consultancy":[751,756],"Fees;":[752],"Fees.":[757],"Kanter:":[758],"Fulcrum":[759,831],"Therapeutics,":[760],"Inc.:":[761],"Consultancy;":[762,827],"Consultancy,":[764,777],"Honoraria,":[765,778,790,802,814],"Membership":[766,779,791,803,815],"on":[767,780,792,804,816],"entity's":[769,782,794,806,818],"Board":[770,783,795,807,819],"Directors":[772,785,797,809,821],"advisory":[774,787,799,811,823],"committees;":[775,788,800,812,824],"Forma:":[776],"Beam:":[801],"Sanofi:":[813],"Graphite":[825],"GuidePoint":[828],"Global:":[829],"Tx:":[832],"Consultancy.":[833],"Lee:":[834],"Chiesi":[835,841,847,853],"Canada":[836,842,848,854],"Corp:":[837,843,849,855],"Current":[838,844,850,856],"Employment.":[839,845,851,857],"Temin:":[840],"Fradette:":[846],"Tricta:":[852]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-11-22T00:00:00"}